On September 28, 2020 BRG Team participated in the official opening of the Celon Pharma Research and Development Center, an innovative biopharmaceutical company engaged in research, development, production and sale of pharmaceutical products. The new facility, with an area of ​​over 30,000 m2, is equipped with the most modern research infrastructure in Poland, in which 350 scientists will eventually implement 16 new drug development projects in 4 therapeutic areas: neuropsychiatry, oncology, metabolic diseases, and inflammatory diseases. The facility has innovative biotechnology laboratories, equipped with into single use, chemical and physicochemical technologies - enabling the synthesis of compounds on a large scale based on the use of flow chemistry reactors or biomarkers - enabling work on markers and tests for personalized therapy of civilization diseases BioResearch Group collaborates with Celon Pharma to test new, innovative therapies. Over the course of 4 years, our center has successfully conducted early-phase studies for drugs from various medical areas that were first administered to humans. This stage of the study is carried out under very strict rules, requiring close monitoring of pharmacokinetics and / or pharmacodynamics. The effects achieved by Celon Pharma and BioResearch show how valuable cooperation can be and how you can effectively create progress in medicine and implement innovative therapies into everyday life. We were distinguished by the opportunity to participate in this inspiring event. The BRG team was among a small group of guests who were invited directly to the headquarters of the RESEARCH AND DEVELOPMENT CENTER. Due to the pandemic, most of the participants participated in the event remotely.